These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27155327)

  • 1. Livedoid vasculopathy - a challenging disease.
    Vieira R; Bernardes JM; Pinto JA; Costa L
    Acta Reumatol Port; 2016; 41(3):273-274. PubMed ID: 27155327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.
    Browning CE; Callen JP
    Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin.
    Davis MD; Wysokinski WE
    J Am Acad Dermatol; 2008 Mar; 58(3):512-5. PubMed ID: 18280355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe livedoid vasculopathy associated with antiphosphatidylserine-prothrombin complex antibody successfully treated with warfarin.
    Noda S; Asano Y; Yamazaki M; Ichimura Y; Tamaki Z; Takekoshi T; Sugaya M; Sato S
    Arch Dermatol; 2011 May; 147(5):621-3. PubMed ID: 21576587
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary livedoid vasculopathy associated with mononeuritis multiplex.
    Krueger S; McLean R; Amano S; Belazarian L
    Dermatol Online J; 2020 Jul; 26(7):. PubMed ID: 32898400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous prothrombin gene mutation associated with livedoid vasculopathy.
    Anavekar NS; Kelly R
    Australas J Dermatol; 2007 May; 48(2):120-3. PubMed ID: 17535202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mononeuropathy multiplex in association with livedoid vasculitis.
    Toth C; Trotter M; Clark A; Zochodne D
    Muscle Nerve; 2003 Nov; 28(5):634-9. PubMed ID: 14571469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
    Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
    Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensory ganglionopathy with livedoid vasculopathy controlled by immunotherapy.
    Alix JJ; Hadjivassiliou M; Ali R; Slater D; Messenger AG; Rao DG
    Muscle Nerve; 2015 Feb; 51(2):296-301. PubMed ID: 25196820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Livedoid vasculopathy and peripheral neuropathy: A retrospective cohort study of 55 Chinese patients and literature review.
    Gao Y; Jin H
    Int Wound J; 2023 May; 20(5):1498-1505. PubMed ID: 36333819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin.
    Kavala M; Kocaturk E; Zindanci I; Turkoglu Z; Altintas S
    J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of livedoid vasculopathy with short-cycle intravenous immunoglobulins.
    Pitarch G; Rodríguez-Serna M; Torrijos A; Oliver V; Fortea JM
    Acta Derm Venereol; 2005; 85(4):374-5. PubMed ID: 16191872
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of intravenous immunoglobulins in livedoid vasculopathy: long-term follow-up of 11 patients.
    Monshi B; Posch C; Vujic I; Sesti A; Sobotka S; Rappersberger K
    J Am Acad Dermatol; 2014 Oct; 71(4):738-44. PubMed ID: 25022849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Livedoid vasculopathy associated with peripheral neuropathy: a report of two cases.
    Tubone MQ; Escobar GF; Peruzzo J; Schestatsky P; Maldonado G
    An Bras Dermatol; 2013; 88(6 Suppl 1):227-9. PubMed ID: 24346927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs--a prospective study.
    Di Giacomo TB; Hussein TP; Souza DG; Criado PR
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1340-6. PubMed ID: 20337814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic leg ulcerations associated with livedoid vasculopathy successfully treated with rivaroxaban.
    Miguel D; Elsner P; Goetze S
    Clin Exp Dermatol; 2020 Jan; 45(1):120-122. PubMed ID: 30767258
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful use of rituximab in a patient with recalcitrant livedoid vasculopathy.
    Zeni P; Finger E; Scheinberg MA
    Ann Rheum Dis; 2008 Jul; 67(7):1055-6. PubMed ID: 18556452
    [No Abstract]   [Full Text] [Related]  

  • 18. Peripheral neuropathy and livedoid vasculopathy.
    Soulages A; Maisonobe T; Auzou P; Petit A; Allenbach Y; Barète S; Skopinski S; Ribeiro E; Jullié ML; Lamant L; Brevet F; Soulages X; Vallat JM; Martin-Négrier ML; Solé G; Duval F; Carla L; Le Masson G; Mathis S
    J Neurol; 2022 Jul; 269(7):3779-3788. PubMed ID: 35166926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vasculitis and vasculopathy].
    Marković A
    Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases.
    Hairston BR; Davis MD; Gibson LE; Drage LA
    Arch Dermatol; 2003 Aug; 139(8):987-90. PubMed ID: 12925383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.